Bayer(BAYRY)
LEVERKUSEN, Germany
Pharmaceutical61 H-1B visas (FY2023)Focus: Biotech / Pharma / Chemical Giant
Error: Unreachable/Blocked
OncologyCardiovascularHematologyOphthalmology
Funding Stage
PUBLIC
Employees
100,000
Open Jobs
4
Products & Portfolio (23)
27 discontinued products not shown
ADEMPAS
riociguat
Peak
ORAL · TABLET
Guanylate Cyclase Stimulators
inoperable CTEPH to improve exercise capacityfunctional class(WHO Group 4) after surgical treatment+5 more
2013
0
ALEVE
naproxen sodium
LOE Approaching
ORAL · TABLET
minor achespains due to: minor pain of arthritis muscular aches backache menstrual cramps headache toothache the common cold temporarily reduces fever
1994
30
ALEVE PM
diphenhydramine hydrochloride and naproxen sodium
Peak
ORAL · TABLET
2014
30
ANGELIQ
drospirenone and estradiol
Peak
ORAL · TABLET
Estrogen Receptor Agonists
moderate to severe vasomotor symptoms due to menopause in a woman with a uterusmoderate to severe vasomotor symptoms associated due to menopause in a woman with a uterusmoderate to severe symptoms of vulvar+2 more
2005
0
ASTEPRO ALLERGY
azelastine hcl
LOE Approaching
NASAL · SPRAY, METERED
2021
15
BETASERON
interferon beta-1b
LOE Approaching
SUBCUTANEOUS · VIAL
(interferon beta-1b) in patients with multiple sclerosis is unknown.
relapsing forms of multiple sclerosisto include clinically isolated syndromerelapsing-remitting disease+2 more
1993
30
BEYAZ
drospirenone/ethinyl estradiol/levomefolate calcium and levomefolate calcium
Peak
ORAL · TABLET
ovulation.
symptoms of premenstrual dysphoric disorder (PMDD) in females of reproductive potentialmoderate acne vulgaris in females of reproductive potential at least 14 years of agefemales of reproductive potential+5 more
2010
8
CHILDREN'S ASTEPRO ALLERGY
azelastine hcl
LOE Approaching
NASAL · SPRAY, METERED
2021
15
CHILDREN'S CLARITIN
loratadine
LOE Approaching
ORAL · TABLET, CHEWABLE
these symptoms due to hay feverother upper respiratory allergies:
2006
30
CIPRO
ciprofloxacin
LOE Approaching
ORAL · FOR SUSPENSION
[see Microbiology ()].
plagueincluding pneumonicsepticemic plague+37 more
1997
45
CLARITIN
loratadine
LOE Approaching
ORAL · CAPSULE
these symptoms due to hay feverother upper respiratory allergies: runny nose itchywatery eyes sneezing itching of the nose+1 more
2008
30
CLARITIN
loratadine
LOE Approaching
ORAL · TABLET, CHEWABLE
these symptoms due to hay feverother upper respiratory allergies:
2006
30
Pipeline & Clinical Trials
No Intervention
Chronic Kidney DiseaseClinical Trials (5)
NCT05004428A Study to Learn More About Chronic Kidney Disease (CKD) in Patients With Type 2 Diabetes Mellitus (T2DM)
N/ANCT04010240A Retrospective Study to Determine the Incidence of NTRK Fusions. NTRK Study
N/ANCT03605810Study to Develop a Tool to Estimate the Kidney Function in Databases Without Laboratory Data
N/A+2 more
Aflibercept
Macular DegenerationClinical Trials (5)
NCT02305238Japanese Treat and Extend Study of Aflibercept in Neovascular Age-related Macular Degeneration
Phase 4NCT03169660Intravitreal Aflibercept for Submacular Hemorrhage
Phase 4NCT02072408Efficacy and Safety of Intravitreal Vascular Endothelial Growth Factor Trap-eye in Patients With Polyploidal Choroidal Vasculopathy
Phase 4+2 more
BAY987516
Sunscreening AgentsClinical Trials (5)
NCT02822261Sun Protection Factor Assay
N/ANCT02803060Sun Protection Factor Assay
N/ANCT0275156718776 - Human Photoallergy Test
N/A+2 more
Coppertone
Sunscreening AgentClinical Trials (5)
NCT038410324 Week In-Use Study Evaluating How Well-Tolerated a Skin Care Product Is on Adults With Facial Redness
N/ANCT0275701418613 - Sun Protection Factor Assay
N/ANCT0277982918432-Sun Protection Factor Assay
N/A+2 more
Rivaroxaban
Atrial FibrillationClinical Trials (5)
NCT05797376Effects of aSPIrin Versus Aspirin Plus Low-dose RIvaroxaban on Carotid aTherosclerotic Plaque Inflammation
Phase 4NCT04853719Rivaroxaban 2.5 mg BID and Aspirin for Intermittent Claudication in PAD Patients
Phase 4NCT04073316AntiCoagulants and COGnition
Phase 4+2 more
Damoctocog alfa pegol
Hemophilia AClinical Trials (5)
NCT04085458Study to Gain More Information on How Safe and Effective Jivi Works in Patients With Severe Hemophilia A (Post-marketing Investigation)
Phase 4NCT05147662A Study to Learn How Safe the Study Treatment BAY94-9027 is and How it Affects the Body in Previously Treated Children Aged 7 to Less Than 12 Years With Severe Hemophilia A, a Genetic Bleeding Disorder That is Caused by the Lack of a Protein Called Clotting Factor 8 (FVIII) in the Blood
Phase 3NCT03932201Evaluating Effectiveness and Long Term Safety of Damoctocog Alfa Pegol in Patients, Who Have Been Diagnosed With Hemophilia A
N/A+2 more
Sorafenib
Carcinoma, Renal CellClinical Trials (5)
NCT00352859Phase IV Randomization to On-Going Treatment to Evaluate Sustained Sorafenib
Phase 4NCT00494299Phase III Study of BAY43-9006 in Patients With Advanced Hepatocellular Carcinoma (HCC) Treated After Transcatheter Arterial Chemoembolization (TACE)
Phase 3NCT00625378Sorafenib Long Term Extension Program
Phase 3+2 more
Kovaltry
Hemophilia A, CongenitalClinical Trials (5)
NCT04565236A Post Approval Commitment Study to Gain More Information on How Safe and Effective KOVALTRY is in Chinese Children, Adolescents /Adults With Severe Hemophilia A
Phase 4NCT01311648BAY81-8973 Pediatric Safety and Efficacy Trial
Phase 3NCT02941783Drug Use Investigation of Kovaltry in Hemophilia A Patients
N/A+2 more
Coppertone
Sunscreening AgentClinical Trials (1)
NCT02822300Sun Protection Factor Assay
N/ACognitive evaluation
Multiple SclerosisClinical Trials (1)
NCT02391064Validation of Brief Computerized Cognitive Assessment in Multiple Sclerosis (BCCAMS)
N/ALanthanum Carbonate
HyperphosphatemiaClinical Trials (5)
NCT02237534Lanthanum Versus Calcium Carbonate for Vascular Abnormalities in Patients With CKD and Hyperphosphatemia
Phase 4NCT01110629Study in Chronic Kidney Disease (CKD) Not on Dialysis
Phase 3NCT01518387Open Study of BAY77-1931 (Lanthanum Carbonate) in Continuous Ambulatory Peritoneal Dialysis Patients
Phase 3+2 more
BPI 1000013
Osteoarthritis, KneeClinical Trials (1)
NCT03556787An Evaluation of a Gender Specific Insole to Provide Relief From Knee Pain Due to Osteoarthritis or General Anterior Knee Pain in Male Subjects When Used in Foot Wear Over a Period of Four Weeks
N/AN/A
Clinical Trials (5)
NCT05658458A Study to Learn How Well the Drug Vericiguat Works and How Safe it is Under Real World Conditions in Indian Participants After Worsening of a Long-term Heart Condition in Which the Left Side of the Heart Does Not Pump Blood as Well as it Should (Chronic Heart Failure With Reduced Ejection Fraction)
Phase 4NCT01951638Phase IIb Safety and Efficacy Study of Four Dose Regimens of BAY1021189 in Patients With Heart Failure and Preserved Ejection Fraction Suffering From Worsening Chronic Heart Failure (SOCRATES-PRESERVED)
Phase 2NCT01951625Phase IIb Safety and Efficacy Study of Four Dose Regimens of BAY1021189 in Patients With Heart Failure With Reduced Ejection Fraction Suffering From Worsening Chronic Heart Failure (SOCRATES-REDUCED)
Phase 2+2 more
ESS305
ContraceptionClinical Trials (4)
NCT01740687A Study to Evaluate the Effectiveness of Essure Post-NovaSure Radiofrequency Endometrial Ablation Procedure Following a Successful Essure Confirmation Test
N/ANCT02532361Proportion of Hysterectomy After Female Sterilization
N/ANCT02510443Observational Study on Contraception With Essure in France
N/A+1 more
Rivaroxaban
Nonvalvular Atrial FibrillationInterferon-1beta
Multiple SclerosisClinical Trials (1)
NCT00461396Success of Titration, Analgesics, and B.E.T.A Nurse Support on Acceptance Rates in Early Multiple Sclerosis (MS) Treatment With Betaseron
N/ABAY14-2222_Kogenate-FS FVIII
Hemophilia AClinical Trials (1)
NCT02263066Retrospective Study in Chinese Pediatric Hemophilia A Patients With rFⅧ Contained Regular Prophylaxis
N/ALevonorgestrel
MenorrhagiaClinical Trials (5)
NCT02957292A Study to Compare the Menstrual Bleeding Profile Among Jaydess® and Copper Intrauterine Device (IUD) Users. COLIBRI STUDY (Copper and Levonorgestrel IUD Barcelona Research Initiative).
Phase 4NCT02362373Women With Epilepsy: a Pilot Study of PK and PD Anti-epileptic Drug Effects in Levonorgestrel Intrauterine System Users
Phase 4NCT00393198Bleeding Pattern and User Satisfaction During Second Consecutive MIRENA® in Contraception and Treatment of Menorrhagia
Phase 4+2 more
Patients with Atrial Fibrillation
Atrial FibrillationClinical Trials (1)
NCT04099238Burden of Ischemic Stroke and Intake of Oral Anticoagulants in Patients With Atrial Fibrillation in the UK Primary Care
N/ACoppertone
Sunscreening AgentClinical Trials (1)
NCT0271735118841- Sun Protection Factor Assay
N/AIopromide
AngiographyClinical Trials (5)
NCT00244140Ultravist: Safety and Efficacy in Computed Tomography of Head and Body
Phase 3NCT01206257The Safety and toleRability of UltraviSt in Patients Undergoing Cardiac CaTheterization (TRUST)
N/ANCT00876083PMS Study Ultravist-IMAGE, IoproMide (UltrAvist) to Gain Further Information on Tolerability and Safety in X-ray Examination
N/A+2 more
Levonorgestrel IUS
Idiopathic MenorrhagiaClinical Trials (1)
NCT00868153Mirena in Idiopathic Menorrhagia
N/AMoxifloxacin
PneumoniaClinical Trials (5)
NCT01302951Penetration of Moxifloxacin Into Liver Tissue of Patients Undergoing Liver Resection.
Phase 4NCT00629135Moxifloxacin Plus Metronidazole Versus Piperacillin/Tazobactam for the Treatment of Patients With Intra-abdominal Abscesses
Phase 3NCT00164463TBTC Study 27/28 PK: Moxifloxacin Pharmacokinetics During TB Treatment
Phase 2+2 more
Aflibercept
Neovascular GlaucomaClinical Trials (1)
NCT04519619Study to Learn More About Safety of Aflibercept Injection in Japanese Patients With Neovascular Glaucoma (NVG)
N/ACardiac Pathologies in Standard Thoracic CT Imaging
Coronary Artery DiseaseClinical Trials (1)
NCT02904239Cardiac Pathologies in Standard Thoracic CT Imaging
N/AN/A
Coppertone
Sunscreening AgentClinical Trials (1)
NCT0280192918670 - Sun Protection Factor Assay
N/AAbdominal US
Liver CirrhosisClinical Trials (1)
NCT06312826Abbreviated MRI Using Gadoxetic Acid Versus Ultrasonography for Surveillance of Early-stage HCC in Patients at High Risk
N/ALevonorgestrel IUS
ContraceptionClinical Trials (1)
NCT01414140Mirena Post-marketing Surveillance in Japan
N/ABalloon Pulmonary Angioplasty
Chronic Thromboembolic Pulmonary HypertensionClinical Trials (2)
NCT03409588Treatment of Exercise-Induced Pulmonary Vascular Dysfunction After Pulmonary Thromboendarterectomy or Balloon Pulmonary Angioplasty
Phase 2NCT02634203Riociguat Versus Balloon Pulmonary Angioplasty in Non-operable Chronic thromboEmbolic Pulmonary Hypertension
N/ABlood tests
Prostate Cancer MetastaticClinical Trials (1)
NCT03223727Treatment Outcomes in a Non-study Population of Symptomatic mCRPC Patients Treated With Radium-223
N/AExhaled Breath Olfactory Signature
Pulmonary HypertensionClinical Trials (1)
NCT02782026Exhaled Breath Olfactory Signature of Pulmonary Arterial Hypertension
N/AInterferon beta-1b
Multiple SclerosisClinical Trials (5)
NCT01701856Natalizumab De-escalation to Interferon-beta-1b in Patients With Relapsing-remitting Multiple Sclerosis
Phase 4NCT00313976Study to Compare Double-dose Betaferon to the Approved Dose, for Patients With Early Secondary Progressive Multiple Sclerosis (SPMS)
Phase 3NCT00370071Open Label Study to Evaluate Effect, Safety and Tolerability of Betaferon Standard Dose of 250µg in Patients of Chinese Origin With Multiple Sclerosis
Phase 3+2 more
Available Recombinant, and Human Factor VIII products incl. Kogenate FS
Hemophilia AClinical Trials (1)
NCT02396862Patient Functioning and Well-being, Economic, and Clinical Impact of Hemophilia A and Its Treatment
N/ASurvey
Cancer Genomic ProfilingClinical Trials (5)
NCT01592149Survey of Prevalence of Loss of Appetite in Subject With Health Disorders
N/ANCT01071681Survey to Assess Why People Are Not Responding to Treatment in Hypertension
N/ANCT04607889A Study to Learn More About What Japanese Patients With Solid Tumors Think About Taking Medicine That is Based on Their Genetic Information
N/A+2 more
LEP
DysmenorrheaClinical Trials (5)
NCT01413958Effects of Phenylephrine Extended-Release Tablets on Allergy-Related Nasal Congestion (P08498 AM1)
Phase 3NCT00976209Consumer Preference Study of Two Formulations of Phenylephrine Hydrochloride (Study CL2008-15)(P07530)(COMPLETED)
Phase 3NCT04534452Study to Find Out Whether Participants With a History of Stuffy Nose Due to Allergic Reactions in the Nose Would Intend to Buy Drug Phenylephrine Hydrochloride Extended Release Tablets After Receiving it Once in This Study
Phase 3+2 more
Ciprofloxacin
InfectionClinical Trials (5)
NCT00663806A Phase IV Study of Cipro XR in Uncomplicated UTI
Phase 4NCT00669994Trial to Evaluate the Efficacy and Safety of Cipro® XR in Treating Female Patients With Lower Urinary Tract Infections
Phase 4NCT00676533Cipro® XR in Therapeutic Response and Activity (eXtRa) - Assessing Symptom Relief in Urinary Tract Infections
Phase 4+2 more
Observational Study of Efficacy and Safety of Travogen Cream and Travocort Cream in the Treatment of
Skin MycosesClinical Trials (1)
NCT00722189Observational Study of Efficacy and Safety of Travogen Cream and Travocort Cream in the Treatment of Mycoses
N/AInterferon-1beta
Multiple SclerosisClinical Trials (1)
NCT00873340Physical Disability in Patients Treated With Betaferon
N/AStandard of Care
Male HypogonadismClinical Trials (5)
NCT03194646Assess Safety and Efficacy of Vilaprisan in Subjects With Uterine Fibroids
Phase 3NCT00858650Registry of Hypogonadism in Men
N/ANCT02615587Burden of Illness in Atrial Fibrillation
N/A+2 more
Campath
Chronic Lymphocytic LeukemiaClinical Trials (4)
NCT00226512To Determine the Role of Adding Campath-1H or ATG Given In-vivo in Addition to Fludarabine and Low Dose Busulfex on Outcome in Patients Treated With Reduced Intensity Conditioning
Phase 3NCT00142181Phase II Study of Campath-1H Antibody to Treat Waldenstrom's Macroglobulinemia
Phase 2NCT00193466Rituximab and Fludarabine Followed by CAMPATH-1H in Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
Phase 2+1 more
Coppertone
Sunscreening AgentClinical Trials (1)
NCT02803047Sun Protection Factor Assay
N/ACoppertone
Sunscreening AgentClinical Trials (1)
NCT02803008Sun Protection Factor Assay
N/AEE/DRSP
ContraceptionClinical Trials (2)
NCT01331655Clinical Study of a Conventional and Flexible Extended Oral Contraceptive of EE/DRSP With or Without Metafolin in Latin America
Phase 3NCT01198444To Evaluate Compliance to Treatment Regimen (Rate of Deviations From the Prescribed Regimen) in Polish Females Treated With Different Low Dose Oral Contraceptives
N/ARivaroxaban
Non-valvular Atrial FibrillationNo drug
MenorrhagiaClinical Trials (5)
NCT00927667Joint Status in Subjects With Severe Hemophilia A in Relation to Different Treatment Regimens
Phase 4NCT01249664VEGF Trap-Eye in Choroidal Neovascularization Secondary to Pathologic Myopia (mCNV)
Phase 3NCT01643122Validation Study for Endometriosis PRO
N/A+2 more
Lanthanum Carbonate
HyperphosphatemiaClinical Trials (1)
NCT01955876Fosrenol Post-marketing Surveillance in Japan
N/AStandard of care
Hypertension, PulmonaryClinical Trials (1)
NCT02637050A Study Investigating Routine Practice of Chronic Thromboembolic Pulmonary Hypertension Management in EMEA Countries
N/ABAY 987519, SPF 50, Y51-002
Sunscreen AgentsClinical Trials (1)
NCT02857478Supervised Outdoor-Use Test to Assess the Safety of a Sunscreen C-Spray on Sport Users
N/ARecombinant Factor VIII
Hemophilia AClinical Trials (1)
NCT00922597Non-interventional Observation of Practical Implementation, Efficacy and Safety of Continuous Infusion With KOGENATE Bayer in Surgery
N/AOpen Jobs (4)
Machine Operators, Packaging
Turku, Finland
Pharma2w ago
Senior Customer Supply Chain Business Partner Nordics-Baltics
Solna, Sweden (Hybrid)
Pharma3w ago
Tender & Pricing Lead Denmark and Norway
København, Denmark (Hybrid)
Pharma3w ago
Praktikant i forsknings- og utviklingsavdelingen
Oslo, Norway
Pharma1mo ago
Interview Prep Quick Facts
Portfolio: 133 approved products, 220 clinical trials
Top TAs: Oncology, Cardiovascular, Neurology
H-1B (2023): 61 approvals
Publications: 25 in PubMed
Open Roles: 4 active jobs
Portfolio Health
Pre-Launch25 (19%)
Launch2 (2%)
Peak17 (13%)
LOE Approaching78 (59%)
Post-LOE11 (8%)
133 total products
Therapeutic Area Focus
Oncology
8 marketed667 pipeline
Cardiovascular
2 marketed237 pipeline
Neurology
3 marketed98 pipeline
Nephrology
79 pipeline
Women's Health
8 marketed64 pipeline
Metabolic Diseases
66 pipeline
Rare Diseases
62 pipeline
Infectious Diseases
8 marketed36 pipeline
Marketed
Pipeline
Hiring Trend
Actively Hiring
4
Open Roles
+4
Added
-0
Filled/Removed
Based on last 2 crawl cycles
Visa Sponsorship
Sponsors Work Visas
H-1B Petitions (FY2023)
61
Approved
3
Denied
95%
Rate
Source: USCIS H-1B Employer Data Hub